Vaccination with a live-attenuated small-colony variant improves the humoral and cell-mediated responses against Staphylococcus aureus.
Staphylococcus aureus is known to produce persistent and chronic infections in both humans and animals. It is recognized that small-colony variants (SCVs), which produce higher levels of biofilm and that are capable of intracellular persistence, contribute to the chronicity or recurrence of infectio...
Main Authors: | Julie Côté-Gravel, Eric Brouillette, François Malouin |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0227109 |
Similar Items
-
Characterization of a vraG Mutant in a Genetically Stable Staphylococcus aureus Small-Colony Variant and Preliminary Assessment for Use as a Live-Attenuated Vaccine against Intrammamary Infections.
by: Julie Côté-Gravel, et al.
Published: (2016-01-01) -
SigB is a dominant regulator of virulence in Staphylococcus aureus small-colony variants.
by: Gabriel Mitchell, et al.
Published: (2013-01-01) -
Evaluation of a Rhodomyrtus tomentosa ethanolic extract for its therapeutic potential on Staphylococcus aureus infections using in vitro and in vivo models of mastitis
by: Auemphon Mordmuang, et al.
Published: (2019-06-01) -
<i>Staphylococcus aureus</i> Small-Colony Variants from Airways of Adult Cystic Fibrosis Patients as Precursors of Adaptive Antibiotic-Resistant Mutations
by: Guillaume Millette, et al.
Published: (2023-06-01) -
Small Colony Variants of Staphylococcus aureus and Pacemaker-related Infection
by: Harald Seifert, et al.
Published: (2003-10-01)